Skip to main content
Log in

Investigational New Drugs

Novel Anti-Cancer Therapeutics and Therapies

Publishing model:

Overview

Investigational New Drugs is a forum for rapid dissemination of information on new anticancer agents.

  • The journal publishes original articles dealing with anticancer drug development.
  • It provides the fastest possible publication of new discoveries for scientists developing anticancer agents.
  • The journal also publishes proceedings of special workshops and symposia on anticancer drug development.
  • It is open to publishing clinical trials with negative results if they contribute to the understanding of investigational agents.
  • 100% of authors surveyed would likely publish in the journal again.

Editor-in-Chief
  • Eric K. Rowinsky
Impact factor
3.4 (2022)
5 year impact factor
3.5 (2022)
Submission to first decision (median)
3 days
Downloads
424,086 (2023)

Latest articles

Journal updates

Journal information

Electronic ISSN
1573-0646
Print ISSN
0167-6997
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. Biological Abstracts
  5. CLOCKSS
  6. CNKI
  7. CNPIEC
  8. Chemical Abstracts Service (CAS)
  9. Current Contents/Clinical Medicine
  10. Current Contents/Life Sciences
  11. Dimensions
  12. EBSCO
  13. EMBASE
  14. Google Scholar
  15. Japanese Science and Technology Agency (JST)
  16. Medline
  17. Naver
  18. OCLC WorldCat Discovery Service
  19. Pathway Studio
  20. Portico
  21. ProQuest
  22. Reaxys
  23. SCImago
  24. SCOPUS
  25. Science Citation Index Expanded (SCIE)
  26. Semantic Scholar
  27. TD Net Discovery Service
  28. UGC-CARE List (India)
  29. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature

Navigation